<?xml version="1.0" encoding="UTF-8"?>
<p>The studies have been powered to assess non-inferiority of the fractional dose (1/5 
 <sup>th</sup>) compared to full standard dose for each manufacturer independently for the YEFE study and of each lower dose of vaccine (1000, 500 and 250 IU/dose) compared to the full standard vaccine dose for the NIFTY study. Sample size calculations were done using PASS and art2bin on Stata version 15.
</p>
